Pharmaceutical composition comprising dabigatran etexilate, and preparation method, solid preparation and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10881615
APP PUB NO 20170333350A1
SERIAL NO

15525860

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A pharmaceutical composition comprising dabigatran etexilate, and preparation method and use thereof, and solid preparation comprising the pharmaceutical composition; the pharmaceutical composition comprises a vitamin C layer and a dabigatran etexilate layer separated by a semipermeable film layer, and the semipermeable film layer comprises a water-soluble compound, a water-insoluble compound and an optional anti-sticking agent and/or plasticizer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTDNO 369 YUZHOU SOUTH RD LIANYUNGANG JIANGSU 222062 222062

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cai, Jiahui Lianyungang, CN 12 57
Dong, Ping Lianyungang, CN 58 504
He, Xiongxiong Lianyungang, CN 3 1
Huang, Xin Lianyungang, CN 222 787
Zhang, Xiquan Lianyungang, CN 77 63

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 5, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 5, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00